Charles River Laboratories International (NYSE:CRL – Free Report) had its price target lowered by Wells Fargo & Company from $280.00 to $275.00 in a report published on Friday morning, MarketBeat.com reports. Wells Fargo & Company currently has an overweight rating on the medical research company's stock. Several other brokerages also recently issued reports on CRL. […] The post Wells Fargo & Company Cuts Charles River Laboratories International (NYSE:CRL) Price Target to $275.00 first appeared on Daily Political .

https://www.dailypolitical.com/2023/09/23/wells-fargo-company-cuts-charles-river-laboratories-international-nysecrl-price-target-to-275-00.html

#dailypolitical